Bengt Westermark

Bengt Westermark

Directeur/Membre du Conseil chez MEDIVIR AB
81 ans
Health Technology
Commercial Services
Consumer Services

Profil

Bengt Westermark is the founder of Mesenkia Therapeutics AB, serving as Chairman since 2023.
Current jobs include Independent Director at Medivir AB since 2017, Member of the Royal Swedish Academy of Sciences, Professor at the University of Uppsala since 2002, Member of the European Molecular Biology Organization, Member of the Royal Society of Sciences, and Member of The European Academy of Cancer Sciences.
Former jobs include Chairman-Research Board at The Swedish Cancer Society from 2003 to 2013, Independent Director at Medivir AB from 2017 to 2021, and Director at Hamlet BioPharma AB.

Postes actifs de Bengt Westermark

SociétésPosteDébut
MEDIVIR AB Directeur/Membre du Conseil 01/01/2017
Corporate Officer/Principal 01/01/1986
Corporate Officer/Principal -
European Molecular Biology Organization
Corporate Officer/Principal -
Royal Society of Sciences
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Bengt Westermark

SociétésPosteFin
MEDIVIR AB Directeur/Membre du Conseil 05/05/2021
The Swedish Cancer Society
Corporate Officer/Principal 01/01/2013
HAMLET PHARMA AB (PUBL) Directeur/Membre du Conseil -
Voir l'expérience en détail de Bengt Westermark

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Commercial Services

Consumer Services

The Swedish Cancer Society

European Molecular Biology Organization

Health Technology

Royal Society of Sciences

Commercial Services

  1. Bourse
  2. Insiders
  3. Bengt Westermark
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇